STAT

SEPTEMBER 9, 2024

Going to the doctor is already tricky enough for people with chronic symptoms of Lyme disease. Their concerns often dismissed by mainstream medicine, those patients now face an additional hurdle: ruling out long Covid.  The two illnesses — one seeping in over the course of decades and another suddenly springing to life on a massive scale — share many qualities, including being widely misunderstood.

363

363

PharmaVoice

SEPTEMBER 9, 2024

The deal, which targets metabolic diseases, is one of a few by Big Pharma to develop lncRNA therapies.

262

262

STAT

SEPTEMBER 9, 2024

The Biden administration on Monday announced it would finalize a highly anticipated proposal meant to force health insurers to cover mental health care on the same basis as physical health conditions.  It is the latest salvo in a long-running federal government effort to crack down on insurance plans skimping on treatment for conditions including anxiety, depression, and addiction.

363

363

ALiEM - Pharm Pearls

SEPTEMBER 9, 2024

A 61-year-old female with a past medical history of hypertension, hyperlipidemia, type 2 diabetes, and normal pressure hydrocephalus s/p VP shunt (last revision nine months ago) presented to the Emergency Department (ED) for evaluation after noticing a “string” coming out of her anus today. Associated symptoms included nausea and a mild headache for one day, and one episode of vomiting prior to arrival.

Diabetes 152

Diabetes Hospitals 152

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

SEPTEMBER 9, 2024

On Sunday, a small biotech company called Summit Therapeutics won a remarkable victory, saying its experimental drug outperformed Merck’s Keytruda , the world’s best-selling drug, in non-small cell lung cancer, the disease that represents Keytruda’s biggest market. By itself, Summit’s victory would be a dramatic story, although not an unheard of one in the unpredictable world of biotechnology.

Drug Development 356

Drug Development 356

Pharmaceutical Commerce

SEPTEMBER 9, 2024

In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Meghan Mullooly, Archbow Consulting’s Vice President, offers advice to pharma manufacturers for successfully applying digital solutions to their patient support programs.

111

111

PharmaVoice

SEPTEMBER 9, 2024

Setbacks haven’t stopped advances by biotechs and pharmas working on new drugs for the inherited brain disorder.

114

114

STAT

SEPTEMBER 9, 2024

WASHINGTON — The House Monday passed a bill by 306 to 81 votes to make drug companies stop doing business with some Chinese biotechs within eight years if they want to remain in good standing with the federal government. The BIOSECURE Act would prohibit the U.S. government from contracting with, or providing grants to, companies that do business with a “biotechnology company of concern.

Packaging 349

Packaging 349

European Pharmaceutical Review

SEPTEMBER 9, 2024

A report from Frontier Economics has highlighted the major benefit industry clinical trials have had on UK’s economy. For instance, it has supported its growth and the job market, the research showed. Of the 65,000 jobs generated, 21,000 individuals were employed directly by the pharmaceutical industry to deliver trials, according to the data. While industry clinical trials in the UK have reduced , the Association of the British Pharmaceutical Industry (ABPI) stated that if the activity assumes

105

105

STAT

SEPTEMBER 9, 2024

Elite athletes train and compete under a watchful eye. Fans and coaches track and measure every step, roll, or throw. But for athletes with a spinal cord injury, a key facet of their experience is unknown: neuropathic pain. Unlike musculoskeletal pain — say, from breaking your leg — neuropathic pain resides in the nervous system. And treating it is tricky: you can’t just pop an Advil or Tylenol and wait for the pain to subside.

326

326

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

SEPTEMBER 9, 2024

Discover how Chiesi is leading the way in pharmaceutical sustainability by partnering with EcoVadis and implementing innovative practices. Learn how they are making a positive impact on the environment and society.

109

109

STAT

SEPTEMBER 9, 2024

Duchenne muscular dystrophy has seen more progress in the past 15 months (give or take) than in the last couple of decades combined. In that time, the Food and Drug Administration has approved three new therapies: Elevidys (delandistrogene moxeparvovec-rokl), the first micro-dystrophin gene therapy; Duvyzat (givinostat), a non-steroidal HDAC inhibitor; and Agamree (vamorolone), a new corticosteroid.

297

297

The Pharmacist

SEPTEMBER 9, 2024

Pharmacists in England will be allowed to dispense 10% more or less than the prescribed amount in order to dispense medications in the original packs from January 2025. This follows changes to the Human Medicines Regulations (HMRs) that have allowed original pack dispensing (OPD) for private prescriptions since October 2023. Community Pharmacy England (CPE) has […] The post Original pack dispensing allowed from January appeared first on The Pharmacist.

Community Pharmacies 101

Community Pharmacies 101

STAT

SEPTEMBER 9, 2024

NEW YORK — One Brooklyn Health, a safety net hospital system that serves some of this city’s poorest and sickest patients, would seem to be exactly the place to benefit most from the effort to remove race from calculations that assess kidney disease. The patients — mostly Black and insured by Medicaid or Medicare — are a case study in the disparities that run through American kidney care: A large number have advanced disease and require dialysis, but just a handful ge

Hospitals 333

Hospitals 333

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

The Pharmacist

SEPTEMBER 9, 2024

The government has committed to three ‘strategic shifts’ for the NHS which includes moving care from ‘hospital to community’ and from ‘treatment to prevention'. The Labour Government also said it wants to shift the NHS from ‘analogue to digital’, in a statement last week (6 September 2024). The comments come as Lord Darzi's investigation into the […] The post Government promises 'shift' towards community and prevention appeared first on The Pharmacist.

Hospitals 100

Hospitals 100

STAT

SEPTEMBER 9, 2024

CUPERTINO, Calif. — Apple on Monday announced a new Apple Watch feature that will warn users they may have sleep apnea. It’s the latest advance in the company’s decade-long effort to sell its wearable as a tool that can help people live healthier lives. Additionally, the company announced more hearing health features for its wireless earbuds.

321

321

The Pharmacist

SEPTEMBER 9, 2024

Community pharmacy could consider 'working to rule' under GP-style collective action, sector leaders have suggested. Speaking at the Avicenna Heathrow conference yesterday (8 September 2024), both Community Pharmacy England (CPE) and National Pharmacy Association (NPA) leaders said that 'working to rule' and legal action against the government remained a possibility for the sector.

Community Pharmacies 97

Community Pharmacies 97

STAT

SEPTEMBER 9, 2024

With strong data released over the weekend, an experimental Chinese drug showed it could one day become an important therapy for lung cancer patients. But that doesn’t necessarily threaten the market dominance of Keytruda, a top Merck executive said — and some analysts agree. “I see these results as important, but preliminary,” Merck Chief Medical Officer Eliav Barr told STAT, reacting to the presentation Sunday of a Phase 3 clinical trial involving ivonescimab, a dru

309

309

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Express Pharma

SEPTEMBER 9, 2024

Agilisium, a data innovation partner for the life sciences industry, has announced the opening of a new development centre in Hyderabad’s RMZ Spire campus, located in Cybercity. The new office is positioned within a pharmaceutical hub, allowing the company to strengthen its capabilities in offering innovative solutions and enabling closer collaboration with clients.

104

104

STAT

SEPTEMBER 9, 2024

Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in  ads for Opdivo+Yervoy , a combination of immunotherapies to treat metastatic melanoma and lung cancer.  Ads for Skyrizi , a medicine to treat plaque psoriasis and other illnesses, show patients snorkeling and riding bikes — flashing their rash-free elbows.

Diabetes 293

Diabetes 293

Express Pharma

SEPTEMBER 9, 2024

Romaco India inaugurated its Solids Processing Experience Center on the evening of September 4, 2024, in Sultanpur, Hyderabad. Located in the Medical Device Park at the 4th Exit of Outer Ring Road, the facility is designed to provide hands-on experience with advanced solids processing technologies. The centre features a development laboratory and equipment showroom, offering support for key processes like granulation, fluid-bed granulation, drying, pellet coating, hot melt coating, tableting, an

Dosage 104

Dosage 104

STAT

SEPTEMBER 9, 2024

After leading his previous company through a back-to-back IPO and M&A deal, the former chief executive of RayzeBio has raised $370 million to develop autoimmune therapies he believes could be “mega-blockbusters.” Those drugs are being developed by San Diego startup Candid Therapeutics, which launched Monday with financing from more than 20 investors.

290

290

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Express Pharma

SEPTEMBER 9, 2024

On September 8, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 4 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative. The session, which focused on Qualification and Validation, saw participation from over 200 attendees. It underscored the industry’s demand for learning about the Revised Schedule M and its impact on pharmaceutical manufacturing.

Pharmaceutical Manufacturing 99

Pharmaceutical Manufacturing 99

STAT

SEPTEMBER 9, 2024

Relay Therapeutics disclosed encouraging results for its key breast cancer drug and plans to advance the experimental treatment, called RLY-2608, to a late-stage clinical trial, the biotech firm said on Monday. The new data come from an open label phase 1/2 trial on RLY-2608 combined with fulvestrant, an endocrine therapy for breast cancer, showing a third of patients with measurable disease responded to the treatment.

Labelling 284

Labelling Drug Development 284

Pharma Times

SEPTEMBER 9, 2024

Research suggests that LLMs could be used to support trainee doctors, nurses and GPs

117

117

STAT

SEPTEMBER 9, 2024

Highmark Health, a large regional health insurer that also owns a chain of hospitals, is now covering a handful of digital treatments for chronic pain and other conditions for millions of its patients. The move, which could provide a boost to digital therapeutics makers, may feel like déjà vu for close industry observers.  In 2022, Pittsburgh-based Highmark issued a policy stating that it would cover eight Food and Drug Administration-cleared prescription digital therapeutics for

Hospitals 265

Hospitals 265

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

SEPTEMBER 9, 2024

Summit Therapeutics and Akeso's ivonescimab tops Merck's Keytruda in head-to-head phase 3 trial in first-line NSCLC, reported at WCLC.

104

104

STAT

SEPTEMBER 9, 2024

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine.  Sign up  to get it in your inbox every Monday. The hospital power players behind R1 Private equity firms are leading the buyout of R1 RCM, a major provider of billing and administrative services for hospitals and physician groups.

Hospitals 253

Hospitals 253

Express Pharma

SEPTEMBER 9, 2024

Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, has expressed support for the GST Council’s decision to reduce the Goods and Services Tax (GST) on cancer drugs to 5 per cent. Jain emphasised the importance of this move in addressing the growing burden of chronic diseases in India. “We welcome the GST Council’s decision to lower GST on cancer drugs to 5 per cent.

97

97

STAT

SEPTEMBER 9, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Lots of bispecific talk on this delightful September day, as well as discussion around new concerns in Duchenne treatment as more options become available.

Drug Pricing 253

Drug Pricing Drug Development 253

pharmaphorum

SEPTEMBER 9, 2024

AI biomarker could help identify lung cancer patients most likely to benefit from AstraZeneca and Daiichi Sankyo's TROP2 drug Dato-DXd.

97

97